Neuren Pharmaceuticals Limited ( NURPF) - Key Metrics
NURPF Revenue per Share metrics
| Date | Revenue per Share | Net Income per Share | Operating Cash Flow | Free Cash Flow per Share |
|---|---|---|---|---|
| 2025Q4 | $0.29 | $0.12 | -$0.02 | -$0.02 |
| 2025Q2 | $0.22 | $0.12 | $0.99 | $0.99 |
| 2024Q4 | $1.47 | $1.03 | $0.07 | $0.07 |
| 2024Q2 | $0.19 | $0.06 | -$0.16 | -$0.16 |
| 2023Q4 | $1.33 | $0.86 | $1.10 | $1.10 |
NURPF Payout ratio and Price per Earnings ratio
| Date | Payout ratio | PE ratio |
|---|---|---|
| 2025Q4 | ? | 38.25 |
| 2025Q2 | ? | 30.28 |
| 2024Q4 | ? | 3.05 |
| 2024Q2 | ? | 80.47 |
| 2023Q4 | ? | 7.23 |
NURPF
Price: $8.88
52 week price:
Earnings Per Share: 0.16 USD
P/E Ratio: 53.28
Exchange: PNK
Sector: Healthcare
Industry: Biotechnology
Market Capitalization: 1.1 billion